Supplement to: Bitopertin Shows Efficacy in Patients with Erythropoietic Protoporphyria: Results from the Randomized Double-Blind, Placebo-Controlled AURORA Trial

Name: Supplement to: Bitopertin Shows Efficacy in Patients with Erythropoietic Protoporphyria: Results from the Randomized Double-Blind, Placebo-Controlled AURORA Trial
Creator: Amy Dickey
Published: 2025-12-05T00:30:28.830Z
Keywords: Phototoxicity, Porphyria

Dickey, Amy; Bonkovsky, Herbert L.; Balwani, Manisha; Anderson, Karl E.; Levy, Cynthia; Thapar, Manish; Wang, Bruce; Chin, Melanie; Savage, Will; Desnick, Robert; Keel, Sioban

doi:10.17632/3y4dzvrp49.1

Supplement to: Bitopertin Shows Efficacy in Patients with Erythropoietic Protoporphyria: Results from the Randomized Double-Blind, Placebo-Controlled AURORA Trial

Published: 5 December 2025| Version 1 | DOI: 10.17632/3y4dzvrp49.1

Contributors:

Amy Dickey, Herbert L. Bonkovsky, Manisha Balwani, Karl E. Anderson, Cynthia Levy, Manish Thapar, Bruce Wang, Melanie Chin, Will Savage, Robert Desnick, Sioban Keel

Description

Supplemental material to Bitopertin Shows Efficacy in Patients with Erythropoietic Protoporphyria: Results from the Randomized Double-Blind, Placebo-Controlled AURORA Trial

Supplement to: Bitopertin Shows Efficacy in Patients with Erythropoietic Protoporphyria: Results from the Randomized Double-Blind, Placebo-Controlled AURORA Trial

Description

Files

Categories

Licence